This test is most useful if any of these apply to you.
If you've been told you have diabetes, knowing how much insulin your pancreas still makes can help explain your treatment needs. A 24-hour urine C-peptide collection provides an indirect estimate across a day of meals and activity. Blood sugar can look similar in someone producing little insulin and someone producing more insulin to compensate for resistance.
Urinary C-peptide has been used clinically for decades. Its strongest role is assessing your own insulin secretion in selected situations, particularly when repeated blood sampling is difficult. Using the day-long total to screen otherwise healthy adults for early insulin resistance is less established.
Your insulin-making pancreatic cells are called beta cells. They first build a larger molecule called proinsulin, then split it into insulin and C-peptide. The two enter the blood in equal numbers.
Your liver removes a substantial share of insulin on its first pass through, while C-peptide passes through largely untouched and stays in circulation longer. Your kidneys remove and break down much of the C-peptide. Only a small fraction leaves your body unchanged in urine, and that fraction can vary.
The lab measures C-peptide concentration using antibodies and combines it with the collected urine volume to calculate the amount passed in 24 hours. The result is commonly reported in micrograms per 24 hours. It integrates excretion across meals and overnight, but it isn't a direct count of all the insulin you made that day. Studies comparing timed urine collections with blood-based estimates support its use as an indirect measure of secretion.
In type 1 diabetes, the immune system attacks beta cells. Some people continue making small amounts of insulin for years after diagnosis. Studies using sensitive blood measurements and single-sample urine C-peptide-to-creatinine ratios have detected this remaining secretion even after longstanding diabetes. Those measurements differ from the total collected over 24 hours, so their findings cannot be translated directly into a daily urine result.
Injected and pumped insulin contain no C-peptide, which allows testing to assess your own secretion while you use insulin. Detectable C-peptide alone doesn't establish that you make enough insulin to manage without treatment.
Some adults diagnosed with type 2 diabetes have slowly progressing autoimmune diabetes. Inherited forms can also be mistaken for type 1 or type 2. Insulin secretion is one clue to the distinction, alongside your age at diagnosis, disease course, family history, and pancreatic antibody results.
Low secretion with persistently high glucose supports insulin deficiency, which can occur in type 1 diabetes, longstanding type 2 diabetes, or diseases that damage the pancreas. Preserved secretion can occur early in type 1 diabetes, so it doesn't rule that diagnosis out. Current classification guidance primarily uses blood C-peptide paired with a simultaneous glucose measurement. A 24-hour urine total can contribute information, but blood-based interpretations cannot be applied directly to it.
Insulin resistance means your tissues respond less effectively to insulin. Your pancreas may compensate by releasing more, sometimes keeping glucose normal for years. Higher urinary C-peptide can be compatible with that compensation, although food intake, medication, and kidney handling also influence the result.
A small controlled human study found that daily urinary C-peptide adjusted for calorie intake was associated with insulin sensitivity. That adjusted research measure differs from the unadjusted daily total reported by this test. The finding supports studying urinary C-peptide as a metabolic marker; it doesn't establish a standalone diagnosis of insulin resistance or a validated prediction of your future diabetes risk.
There isn't one desirable direction for this marker. Substantial secretion can coexist with high glucose when insulin still isn't meeting your body's needs. A lower result can reflect reduced demand, reduced production, or a change in how your kidneys handle C-peptide.
C-peptide assays aren't fully harmonized across laboratories. Differences in the antibodies and calibration used can produce different numbers from the same sample, so a change after switching labs may partly reflect the measurement method.
Repeated 24-hour urine measurements show meaningful day-to-day variation, even when fasting glucose is similar. A fall alongside worsening glucose can raise concern about insufficient insulin secretion, but diet, medication, collection quality, and kidney handling need to be considered before interpreting it as progression. Your urine trend alone cannot establish whether beta cells are being preserved or lost.
Evidence-backed interventions that affect your C-Peptide level
C-Peptide is best interpreted alongside these tests.